Reassure Stent Patients that Clopidogrel is an Important Heart Med

We're getting questions about the efficacy of long-term clopidogrel (Plavix, etc)...due to a new report from FDA.

This started because of a study suggesting that coronary stent patients taking clopidogrel plus aspirin have a higher risk of death.

The good news is that this risk doesn't pan out when data from several trials are combined.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote